Candel Therapeutics, Inc. Profile Avatar - Palmy Investing

Candel Therapeutics, Inc.

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase I…

Biotechnology
US, Needham [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of CADL's Analysis
CIK: 1841387 CUSIP: 137404109 ISIN: US1374041093 LEI: - UEI: -
Secondary Listings
CADL has no secondary listings inside our databases.